Reducing the risk of left ventricular hypertrophy in kidney transplant recipients: the potential role of mammalian target of rapamycin.

@article{Paoletti2009ReducingTR,
  title={Reducing the risk of left ventricular hypertrophy in kidney transplant recipients: the potential role of mammalian target of rapamycin.},
  author={Ernesto Paoletti and G. Cannella},
  journal={Transplantation proceedings},
  year={2009},
  volume={41 6 Suppl},
  pages={S3-5}
}
Persistence of left ventricular hypertrophy (LVH) following renal transplantation is associated with unfavorable outcomes in renal transplant recipients. This review presents clinical data on LVH after renal transplantation and the role of antihypertensive therapy, especially ACE inhibitors, to reduce left ventricular mass, as well as the effects of interactions between antihypertensive medications acting on the renin-angiotensin system and immunosuppressive agents to regress LVH among renal… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Effect of irolimus on left ventricular hypertrophy in kidney transplant ecipients : a 1 - year non - randomized controlled trial

  • G Stallone, B Infante, A Schena
  • Am J Kidney is
  • 2008

Renal transplantation s not associated with regression of left ventricular hypertrophy : a agnetic resonance study

  • D Hernandez, J Lacalzada, E Salido
  • Clin J Am Soc Nephrol
  • 2008

ACE inhibitors nd persistent left ventricular hypertrophy after renal transplanta - ion : a randomized clinical trial

  • MA Bjornsti, PJ Houghton
  • Am J Kidney Dis
  • 2007

Inhibition of mTOR educes chronic pressure - overload cardiac hypertrophy and fibro - is

  • MO Boluyt, ZB Li, AM Loyd
  • J Hypertension
  • 2006

Early yclosporine withdrawal from a sirolimus - based regimen results in etter renal allograft survival and renal function at 48 months after ransplantation

  • E Raichlin, K Chandrasekaran, WK Kremers
  • Transplant Int
  • 2005

Rapamycin for reatment of chronic allograft nephropathy in renal transplant atients

  • R Oberbauer, G Segoloni, JM Campistol
  • J Am Soc Nephrol
  • 2005

The mTOR / p 70 S 6 K ignaling transduction pathway plays a role in cardiac hypertrophy nd influences expression of myosin heavy chain genes in vivo

  • E Paoletti, M Amidone, P Cassottana
  • ardiovasc Drugs Ther
  • 2004

Electrocardiographic left entricular hypertrophy in renal transplant recipients : prognostic alue and impact of blood pressure and anemia

  • PS Parfrey, JD Harnett, RN Foley
  • J Am Soc Nephrol
  • 2003

Similar Papers

Loading similar papers…